Kawarai M, Koss M C
Department of Pharmacology, University of Oklahoma Health Sciences Center, Oklahoma City 73190.
J Auton Nerv Syst. 1992 Jan;37(1):39-46. doi: 10.1016/0165-1838(92)90143-5.
The present experiments were undertaken to determine, using Laser Doppler flowmetry, if elimination of efferent constrictor mechanisms would unmask cutaneous vasodilator responses following preganglionic sympathetic nerve stimulation in the forepaw of anesthetized cats. We also addressed the question of a potential causal relationship between neurally evoked vasodilator and sudomotor responses. Three separate anti-adrenergic regimens were utilized: (1) acute guanethidine administration (1-2 mg/kg); (2) chronic monoamine depletion with reserpine (5 mg/kg) and alpha-methyl-para-tyrosine (2 x 300 mg/kg); and (3) alpha-adrenoceptor blockade with prazosin (300 micrograms/kg) and yohimbine (0.5 mg/kg). Guanethidine treatment produced a significant depression of basal cutaneous blood flow whereas alpha-adrenoceptor blockade did not. In all three groups, stimulation of the preganglionic thoracic sympathetic nerve trunk produced intensity-dependent increases of digital skin blood flow along with near-maximal sympathetic-cholinergic sudomotor (electrodermal) responses recorded simultaneously from the same paw. Vasodilator responses were not altered by intravenous propranolol (1 mg/kg) or atropine (1 mg/kg); however, evoked sudomotor responses were totally blocked by atropine. Low doses (1.5 mg/kg i.v.) of hexamethonium selectively abolished the cutaneous vasodilator responses but not concomitantly evoked sudomotor responses. These results demonstrate, using direct measurements of blood flow, that cutaneous digital vasodilation can be measured in cats following removal of vasoconstrictor mechanisms either pre- or postjunctionally. Neither muscarinic nor beta-adrenoceptor mechanisms appear to be involved. These experiments also suggest that cutaneous vasodilation is not a consequence of concomitant sudomotor activation.
本实验旨在通过激光多普勒血流仪测定,在麻醉猫的前爪,消除传出性收缩机制是否会揭示节前交感神经刺激后的皮肤血管舒张反应。我们还探讨了神经诱发的血管舒张反应与发汗运动反应之间潜在因果关系的问题。采用了三种不同的抗肾上腺素能方案:(1)急性给予胍乙啶(1-2mg/kg);(2)用利血平(5mg/kg)和α-甲基对酪氨酸(2×300mg/kg)进行慢性单胺耗竭;(3)用哌唑嗪(300μg/kg)和育亨宾(0.5mg/kg)进行α-肾上腺素能受体阻断。胍乙啶治疗使基础皮肤血流量显著降低,而α-肾上腺素能受体阻断则没有。在所有三组中,刺激节前胸交感神经干会使指部皮肤血流量随强度增加,同时从同一只爪子记录到接近最大的交感胆碱能发汗运动(皮肤电)反应。静脉注射普萘洛尔(1mg/kg)或阿托品(1mg/kg)不会改变血管舒张反应;然而,诱发的发汗运动反应完全被阿托品阻断。低剂量(1.5mg/kg静脉注射)的六甲铵选择性地消除了皮肤血管舒张反应,但并未同时消除诱发的发汗运动反应。这些结果通过直接测量血流量表明,在猫身上,去除节前或节后血管收缩机制后,可以测量到指部皮肤血管舒张。毒蕈碱和β-肾上腺素能受体机制似乎均未参与其中。这些实验还表明,皮肤血管舒张不是伴随发汗运动激活的结果。